Ortsbeo IV 1000

Ortsbeo IV 1000, manufactured by Sanofi, contains Efanethoctocog alfa (genetical recombination), a recombinant Factor VIII concentrate used for the treatment and prophylaxis of bleeding in patients with hemophilia A (congenital factor VIII deficiency). This injectable drug (YJ code: 6343459D3020) is typically supplied as 1,000 IU per bottle with a dissolving solution, and is also indicated for on-demand treatment and perioperative management of bleeding.